Marian Vincenzi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Respiratory Syndrome Coronavirus

Top Venues

Molecules (Basel, Switzerland)

Current medicinal chemistry

Journal of medicinal chemistry

Istituto di Biostrutture e Bioimmagini Unità Operativa di Supporto di Napoli Consiglio Nazionale delle Ricerche

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto di Biostrutture e Bioimmagini Unità Operativa di Supporto di Napoli Consiglio Nazionale delle Ricerche Apr 01 2017

Italy

Post-doctoral Fellow

Polska Akademia Nauk Instytut Biologii Medycznej Oct 27 2016 - Mar 31 2017

Poland

PostDoc :: Molecular Virology and Biological Chemistry Lab

Publications

Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone
Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study. Molecules (Basel, Switzerland) 29 (5) (2024)
Marian Vincenzi, Flavia Anna Mercurio, Rosanna Palumbo, Sara La Manna, Luciano Pirone, Daniela Marasco, Emilia M Pedone, Marilisa Leone
Inhibition of the EphA2-Sam/Ship2-Sam Association through Peptide Ligands: Studying the Combined Effect of Charge and Aromatic Character. Journal of medicinal chemistry (2024)
Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone
Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study. Molecules (Basel, Switzerland) 29 (5) (2024)
Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone
Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study. Molecules (Basel, Switzerland) 29 (5) (2024)
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections. Current medicinal chemistry (2023)
Marian Vincenzi, Katarzyna Bednarska, Zbigniew J Leśnikowski
Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay. Molecules (Basel, Switzerland) 23 (8) (2018)